Type 2 diabetes does not appear overnight. By the time your fasting glucose crosses the diagnostic threshold, your body has typically been struggling with the underlying problem for five to fifteen years. During that entire period, your standard annual check-up probably told you everything was fine.

This is one of the most consequential blind spots in preventive medicine. The lab test that could identify the problem early is cheap, widely available, and almost never ordered. Here's what's actually happening during that silent decade, and why we include the relevant marker in our core panel.

What actually happens before diabetes

Your pancreas produces insulin, a hormone that tells your cells to take glucose out of the bloodstream. When the system works normally, a small amount of insulin is enough to keep blood glucose stable.

Over time — especially with weight gain, physical inactivity, poor sleep, and a diet heavy in refined carbohydrates — cells become less responsive to insulin. This is called insulin resistance. The pancreas compensates by producing more insulin. A lot more. At the early stages, glucose looks completely normal on a lab test, because the extra insulin is keeping it in range.

This compensation can go on for years. Your fasting glucose stays under 100. Your HbA1c stays under 5.7%. Your doctor says everything looks fine. Meanwhile, insulin levels are quietly climbing, and the metabolic stress is doing real damage — to your arteries, your liver, your cardiovascular system, and your cognitive health.

Stage 1: Early insulin resistance

Years -15 to -10 before diabetes

Cells start responding less to insulin. The pancreas makes more to compensate. Fasting glucose is normal. HbA1c is normal. Only fasting insulin and HOMA-IR can detect this.

Stage 2: Hyperinsulinemia

Years -10 to -5 before diabetes

Insulin levels are now significantly elevated. Triglycerides may start to rise. Liver enzymes may begin to drift up (fatty liver). Glucose is still normal. A standard check-up still says everything is fine.

Stage 3: Prediabetes

Years -5 to 0 before diabetes

Glucose begins to rise. Fasting glucose enters the 100-125 mg/dL range. HbA1c reaches 5.7-6.4%. This is the first stage most check-ups can detect — but the problem has been brewing for a decade.

Stage 4: Type 2 diabetes

Year 0

Pancreatic beta-cells begin to fail. Glucose crosses the diabetic threshold (≥126 fasting, ≥6.5% HbA1c). By this point, substantial vascular and metabolic damage has often already occurred.

Why the standard tests miss it

The standard metabolic check — fasting glucose and HbA1c — can only see the problem once it has progressed to stage 3 or later. These tests measure the end result of the system failing, not the early warning that it is about to.

Fasting Glucose / HbA1c

Measures what glucose is doing right now. Only abnormal once compensation has failed. Typically detects problems 5-15 years after they started.

Fasting Insulin / HOMA-IR

Measures how hard your pancreas is working to keep glucose normal. Picks up insulin resistance years before glucose becomes abnormal. The early warning system.

What HOMA-IR actually measures

HOMA-IR — the Homeostatic Model Assessment of Insulin Resistance — is a simple calculation that uses your fasting glucose and fasting insulin together. It gives a number that estimates how resistant your cells are to insulin.

  • HOMA-IR < 2.0: Good insulin sensitivity
  • HOMA-IR 2.0–2.5: Early insulin resistance — worth watching
  • HOMA-IR > 2.5: Insulin resistance present — intervene now

The test requires two measurements — fasting glucose (which you'd get anyway) and fasting insulin (which you probably haven't). Insulin costs about ten to fifteen euros to measure. And yet, most standard panels don't include it.

Why early detection matters so much

Here's the part that should genuinely surprise you. The Diabetes Prevention Program — one of the most important trials in preventive medicine — showed that in people with prediabetes, intensive lifestyle intervention reduced the progression to diabetes by 58%. Not 5%. Not 15%. Fifty-eight percent.

"Lifestyle intervention was significantly more effective than metformin at preventing progression to diabetes." — Diabetes Prevention Program, NEJM 2002

The intervention wasn't exotic. It was weight loss of about 7%, 150 minutes of exercise per week, and dietary changes. What made it work was that the intervention happened early enough — while the system was still responsive.

By the time someone is diagnosed with diabetes, beta-cells have already been damaged. Reversal is still possible in some cases, but it's much harder. Every year earlier you catch insulin resistance is a year your pancreas doesn't have to compensate, a year less cardiovascular damage, a year of intact metabolic reserve.

Why this is almost never caught early

Fasting insulin isn't on most standard panels because guidelines are built around diagnostic thresholds, not early detection. The guidelines say "screen for diabetes" — and for that, fasting glucose is enough. But if your goal is to prevent diabetes, not just diagnose it, you need to be looking years earlier.

Beyond HOMA-IR: the full metabolic picture

Insulin resistance rarely travels alone. When we see an elevated HOMA-IR, we usually look at several related markers to understand the full metabolic picture:

  • Triglyceride-to-HDL ratio: a ratio above 2 is a strong indicator of insulin resistance, independent of HOMA-IR
  • Uric acid: often elevated in metabolic syndrome, independent cardiovascular risk factor
  • ALT (liver enzyme): often drifts upward with fatty liver — an early consequence of insulin resistance
  • hs-CRP: measures systemic inflammation, which accompanies metabolic dysfunction
  • Waist circumference and visceral fat (via DEXA or BIA): the fat around your organs matters far more than the fat under your skin

Together, these markers paint a much more accurate picture than fasting glucose alone. They tell us not just whether you have a problem, but how severe it is and what the right intervention should be.

What we do at Health Detectors

The DETECT panel includes fasting glucose, HbA1c, fasting insulin with HOMA-IR calculation, triglycerides, HDL, uric acid, ALT, and hs-CRP. All in the core panel. All included — because we built this program around the markers that matter earliest.

If HOMA-IR is elevated, or if any of the related markers suggest metabolic stress, we activate the METABOLIC module: abdominal ultrasound to assess liver steatosis, DEXA for body composition and visceral fat quantification, and an extended lipid panel. Most importantly, the physician sits down with you to build a targeted intervention plan — not a generic "eat better and exercise" conversation, but a specific plan based on what your data actually shows.

If HOMA-IR is normal, we don't activate the module. That's how evidence-based preventive medicine works: the test directs the next step, not the marketing.

References

  1. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.
  2. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
  3. McLaughlin T, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139(10):802-809.
  4. Matthews DR, et al. Homeostasis model assessment: insulin resistance and beta-cell function. Diabetologia. 1985;28(7):412-419.
  5. Tabák AG, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes (Whitehall II). Lancet. 2009;373(9682):2215-2221.
  6. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2024;47(Suppl 1).